Login to Your Account

Positive Breast Cancer Study Boosts Celldex Therapeutics

By Peter Winter
BioWorld Insight Editor

Monday, December 10, 2012
Shares of Celldex Therapeutics Inc. gained 25.5 percent Monday – a reaction to the company reporting positive final data on CDX-011 in a Phase II study in metastatic breast cancer.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription